ReviewActa pharmaceutica Sinica. B2022

Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds.

Hui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.